Robert J. Zimmerman
Board Member
Research and Development
Parvus Therapeutics
Canada
Biography
Bob has over 25 years experience in translational R&D in both public and privately held companies. A track-record of successful IND filings, product approvals, and new indications support. Independent consultant to the biopharmaceutical industry on pipeline evaluations, drug development strategies, non-clinical programs to support regulatory filings and clinical development, and R&D strategy.
Research Interest
Biopharmaceutical
